You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
McKesson
Harvard Business School
Moodys
Merck

Last Updated: March 28, 2020

DrugPatentWatch Database Preview

Litigation Details for Endo Pharmaceuticals Inc. v. Impax Laboratories Inc. (D. Del. 2008)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Endo Pharmaceuticals Inc. v. Impax Laboratories Inc. (D. Del. 2008)

Docket   Start Trial Date Filed 2008-01-25
Court District Court, D. Delaware Date Terminated 2009-02-24
Cause 35:271 Patent Infringement Assigned To Katharine S. Hayden
Jury Demand None Referred To
Parties ENDO PHARMACEUTICALS INC.; IMPAX LABORATORIES INC.; PENWEST PHARMACEUTICALS CO.
Patents 4,839,177; 4,851,229; 4,892,741; 5,128,143; 5,662,933; 5,958,456; 7,276,250
Attorneys Jack B. Blumenfeld; Julia Heaney; Mary Matterer
Firms Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Endo Pharmaceuticals Inc. v. Impax Laboratories Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Endo Pharmaceuticals Inc. v. Impax Laboratories Inc. (D. Del. 2008)

Date Filed Document No. Description Snippet Link To Document
2008-01-25 1 Complaint Pat. No. 4.839.177, hereby incorporated by reference ' herein in its entirety. In that patent. the support… Pat. No. 4,839,177, hereby incorporated by reference herein in its entirety. ln that patent, the support…United States Patent Nos. 5,662,933 (“the ‘933 patent”) and 5,958,456 (“the ‘456 patent”). This action…United Stat€S Patent 1191 [11] Patent~Number~: 5,662,933' Baichwal et al. [45] Date of Patent: *Sep. 2,…States Patent [19] [11] Patent Number: 5,958,456 Baichwal et al. PageZ of 16 -[45] Date of Patent: *Sep External link to document
2008-09-05 14 Motion to Transfer Case Pat. No. 4,839,177, hereby incorporated by reference herein in its entirety. ln that patent, the support… Pat. No. 4,839,177, hereby incorporated by reference herein in its entirety. In that patent, the support…infringing U.S. Patent No. 5,662,933 (the “’933 patent”) and U.S. Patent No. 5,958,456 (the “’456 patent”) by submitting…the ’456 patent and/or prior patents in the same patent family. 27. On its face, the ’456 patent was filed…United States Patent No. 5,958,456 (“the ‘456 patent”). This action is based upon the Patent Laws of the External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Medtronic
McKinsey
Boehringer Ingelheim
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.